Affiliation:
1. Department of Obstetrics and Gynaecology, The Fourth People's Hospital of Wuxi, Wuxi, Jiangsu Province, China
Abstract
OBJECTIVE: The slit homologue 2 ( SLIT2) gene is a tumour suppressor gene. This study investigated the methylation status of the SLIT2 promoter in women with ovarian cancer in terms of identifying whether this might aid the early diagnosis of ovarian cancer. METHODS: Using methylation-specific polymerase chain reaction analysis, the methylation status of the SLIT2 promoter was measured in tumour tissue and serum samples from 36 patients with ovarian cancer and in matched serum samples from 25 controls without cancer. RESULTS: Aberrant methylation of the SLIT2 promoter was present in ovarian tissue from 29/36 (80.6%) ovarian cancer patients, but not in the 25 healthy controls. Among the cases with hypermethylation in their ovarian tissue, 27/29 (93.1%) of the case-matched serum DNA samples, including all four cases of early-stage ovarian cancer, showed hypermethylation of the SLIT2 promoter. CONCLUSIONS: Hypermethylation of the SLIT2 promoter may be a relatively early event in ovarian cancer; thus, its detection may be an effective approach to improve early diagnosis.
Subject
Biochemistry (medical),Cell Biology,Biochemistry,General Medicine
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献